P953: PHASE I STUDY OF TQB3602 CAPSULE, AN ORAL PROTEASOME INHIBITOR, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

• W. Tang,
• Y. Li,
• X. Zhong,
• Q. Liang,
• Y. Liu,
• Y. Zeng,
• B. Fang,
• L. Zheng,
• T. Niu

Affiliations

W. Tang

1 Department of Hematology, West China Hospital, Sichuan University, Chengdu

Y. Li

1 Department of Hematology, West China Hospital, Sichuan University, Chengdu

X. Zhong

1 Department of Hematology, West China Hospital, Sichuan University, Chengdu

Q. Liang

1 Department of Hematology, West China Hospital, Sichuan University, Chengdu

Y. Liu

2 Department of Hematology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou

Y. Zeng

3 Department of Hematology, First Affiliated Hospital of Kunming Medical University, Hematology Research Center of Yunnan Province, Kunming

B. Fang

2 Department of Hematology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou

L. Zheng

4 GCP Center/National Institute of Drug Clinical Trial, West China Hospital, Sichuan University, Chengdu, China

T. Niu

1 Department of Hematology, West China Hospital, Sichuan University, Chengdu